Clinical Trials Logo

Clinical Trial Summary

Starting in early-perimenopause, changes in systemic and tissue level metabolism result in an accelerated loss of muscle mass and an increase in body fat. Our preliminary work indicates that metabolic alterations, specifically a decrease in whole-body protein balance, increase in abdominal adiposity, and reduced metabolic flexibility during exercise is most evident in perimenopause. Exercise is a potent stimulator of skeletal muscle insulin sensitivity. High intensity interval training (HIIT) has been shown to be an effective exercise strategy to support cardiometabolic health in overweight and obese young women. Skeletal muscle is critical to maintaining metabolic health and functionality across the lifespan, and is considered the primary diver of whole-body insulin resistance.There is a significant decrease in muscle mass across the menopause transition, which is often exacerbated by a significant gain in fat mass and visceral fat. Protein consumption prior to HIIT has resulted in improvements in energy expenditure and fat oxidation in young women. The overarching objective of this study is to determine the metabolic response of HIIT compared to traditional aerobic exercise in early and late perimenopausal women. Aim 1 will examine the metabolic responses (glucose, insulin sensitivity, energy expenditure) of HIIT vs aerobic exercise, combined with pre-exercise carbohydrate or protein ingestion, in overweight/obese (BMI: 28-40 Kg/m^2) early and late perimenopausal women. Aim 2 will explore the impact of perimenopause on the fat oxidation and protein turnover before and after exercise. Lastly, aim 3 will explore the modulating effect of intramuscular fat on these metabolic outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06098183
Study type Interventional
Source University of North Carolina, Chapel Hill
Contact Abbie Smith-Ryan, PhD
Phone 919-962-2574
Email abbiesmith@unc.edu
Status Recruiting
Phase N/A
Start date March 22, 2024
Completion date July 31, 2027

See also
  Status Clinical Trial Phase
Completed NCT05617287 - An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause N/A
Recruiting NCT06192641 - Melatonin Use in Patients With Climacterious Symptoms in the Perimenopause Phase 2
Recruiting NCT05156814 - Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women Phase 4
Completed NCT01475513 - Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women Phase 4
Not yet recruiting NCT01481025 - Efficacy and Safety for Cimicifuga/Hypericum Product Phase 3
Not yet recruiting NCT05922800 - Effectiveness of Electro-Press Needle and Gamma-Oryzanol for Menopause-associated Hot Flashes N/A
Recruiting NCT03951194 - Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women Phase 2/Phase 3
Not yet recruiting NCT04190927 - A New Hormone Replacement Paradigm: Physiologic Restoration Study Phase 4
Completed NCT03178695 - Inovium Ovarian Rejuvenation Trials Phase 1
Active, not recruiting NCT04444245 - Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF Phase 1
Terminated NCT03003949 - The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood Phase 4
Completed NCT03740009 - Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause" Phase 4
Completed NCT03220672 - Effectiveness of Assessment and Educational Intervention on Motor Control of the Pelvic Floor Muscle in Women N/A
Recruiting NCT06227858 - Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated With Perimenopause in Healthy Women N/A
Recruiting NCT04995107 - Effectiveness of Electro-Press Needle for Menopause-associated Hot Flashes N/A